Barksdale Announces All Existing Convertible Debentures Held by Delbrook Capital Advisors Extended to December 31, 2028

Vancouver, British Columbia–(Newsfile Corp. – January 7, 2026) – Barksdale Resources Corp. (TSXV: BRO) (OTCQB: BRKCF) (“Barksdale” or, the “Company“) announces that it is seeking TSX Venture Exchange (“TSXV“) acceptance to amend the terms of its debentures and associated warrants held by investment funds managed by Delbrook Capital Advisors Inc. (“Delbrook“) as follows: (i) extend the maturity […]

1Play and MOONTON Games Introduce First Official M Series Trading Card Collection in Multi-Year Strategic Partnership

Singapore, Jan. 07, 2026 (GLOBE NEWSWIRE) — MOONTON Games, the international video game company behind Mobile Legends: Bang Bang (MLBB), has announced a multi-year strategic partnership with 1Play, a rising brand in youth-focused cultural collectibles. As the Official Trading Card Partner of the M7 World Championship (M7), 1Play will roll out a multi-year lineup of

1Play and MOONTON Games Introduce First Official M Series Trading Card Collection in Multi-Year Strategic Partnership

1Play and MOONTON Games Introduce First Official M Series Trading Card Collection in Multi-Year Strategic Partnership GlobeNewswire January 08, 2026 Singapore, Jan. 07, 2026 (GLOBE NEWSWIRE) — MOONTON Games, the international video game company behind Mobile Legends: Bang Bang (MLBB), has announced a multi-year strategic partnership with 1Play, a rising brand in youth-focused cultural collectibles.

Conavi Medical Corp. Announces Filing of Amended & Restated Final Prospectus

(TSX-V:CNVI),(OTC US:CNVIF),(Other OTC:CNVIF), NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES A&R FINAL PROSPECTUS WILL BE ACCESSIBLE ON SEDAR+ TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (“Conavi” or the “Company“), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging

Conavi Medical Corp. Announces Filing of Amended & Restated Final Prospectus

Conavi Medical Corp. Announces Filing of Amended & Restated Final Prospectus GlobeNewswire January 08, 2026 NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES A&R FINAL PROSPECTUS WILL BE ACCESSIBLE ON SEDAR+ TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (“Conavi” or the “Company“), a

Minim Martap Development Update

(AUST:CAY),(AUST:CAY.AX), Highlights The surface miner has arrived in Cameroon, with mining operations scheduled to commence in February 2026. Delivery of locomotives and wagons scheduled in Q1, 2026. Ore haulage from the Inland Rail Facility to the Port of Douala is planned for Q2, 2026, supporting first bauxite shipment targeted for late June 2026. Recruitment of

Minim Martap Development Update

Minim Martap Development Update GlobeNewswire January 08, 2026 Highlights The surface miner has arrived in Cameroon, with mining operations scheduled to commence in February 2026. Delivery of locomotives and wagons scheduled in Q1, 2026. Ore haulage from the Inland Rail Facility to the Port of Douala is planned for Q2, 2026, supporting first bauxite shipment

Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock

(CNSX:DRUG.CN),(CNSX:DRUG),(NASDAQ:DRUG), NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company“) announces the pricing of its previously announced public offering of 1,945,000 common shares in the capital of the Company (the “Common Shares“) at a price of $90.00 per Common Share for anticipated gross

Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock

Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock GlobeNewswire January 08, 2026 NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company“) announces the pricing of its previously announced public offering of 1,945,000 common shares in the capital

Scroll to Top